期刊文献+

复方甘草酸苷注射液致不良反应7例分析 被引量:3

暂未订购
导出
摘要 复方甘草酸苷注射液具有保护肝细胞膜、抗感染、抗变态反应、免疫调节、抑制病毒增殖和灭活、解毒等多种药理活性,临床上常用于治疗慢性肝病,改善肝功能,以及治疗湿疹、皮肤炎、荨麻疹,皮肤科还用于治疗紫癜、水痘、寻常性银屑病、带状疱疹等疾病,发生过敏反应者较少见。现将我院近几年应用复方甘草酸苷注射液引发不良反应7例汇总报道如下,希望引起临床高度重视。
出处 《药学研究》 CAS 2013年第4期245-246,共2页 Journal of Pharmaceutical Research
基金 山东省中医药科技发展计划(2009184)
  • 相关文献

参考文献4

二级参考文献22

  • 1卫鹏,马晓玲.复方甘草酸苷注射液致过敏1例[J].临床医药实践,2008,17(1). 被引量:3
  • 2陈耀凯,王宇明,方蓉.复方甘草酸苷联合拉米夫定治疗慢性乙型肝炎的疗效观察[J].中国药房,2006,17(7):522-524. 被引量:9
  • 3尹伟.大剂量应用甘草甜素片致全身浮肿2例[J].中国医院药学杂志,1999,19(5):317-317.
  • 4[1]Hiromitsu Kumada.Long- term treatment of chronic hepatitis C with glycyrrhizin[stronger neo- minophagen C(SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma[J]. Oncology, 2002,62,(1):94.
  • 5[2]Ohtsuki K.Separation of phospholipase A2 in Habu snake venom by glycyrrhizin(GL)- affinity column chromatography and identification of a GL- sensitive enzyme[J]. Biol Pharm Bull, 1998,21:574.
  • 6[3]Shimoyama Y.Physiological correlation between glycyrrhizin,glycyrrhizin- binding lipoxygenase and casein kinase Ⅱ [J].FFBS Lett, 1996,391:238.
  • 7[4]Zhang Y.Bidirectional control by glycurrhizin of the growth response of lymphocytes stimulated through a receptor- bypassed pathway[J]. Immunol Lett ,1992,32:147.
  • 8[5]Kimura M.Selective activation of extrathymic T cells in the liver by glycyrrhizin[J]. Biotherapy ,1992,5:167.
  • 9[6]Takahara T,Watanabe A, Shiraki K.Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study[J]. J Hepatol, 1994,21:601.
  • 10[7]Sato H, Goto W, Yamamura J.Therapeutic basis of glycyrrhizin on chronic hepatitis B[J]. Antivir Res,1996,30:171.

共引文献169

同被引文献59

  • 1朱艳兰.复方甘草酸苷致过敏性休克一例报告[J].青海医药杂志,2012,42(11):3-3. 被引量:1
  • 2李迎.环磷腺苷治疗寻常性银屑病临床疗效观察[J].临床皮肤科杂志,2007,36(8):533-534. 被引量:7
  • 3Zenone T,Blanc Q.Rhabdomyolysis with major hypokalemia secondary to chronic glycyrrhizic acid ingestion[J].Rev Med lnterne,2009,30(1):78.
  • 4Barrella M,Lauria G,Quatrale R,et al.Hypokaliemic rhabdomyolysis associated with liquorice ingestion:report of an atypical case[J].Ital J Neurol Sci,1997,18(4):217.
  • 5Fredriksson T, Pettersson U. Severre psoriasis oral therapy with a new retinoid [J]. Dematologica, 1978,157:238 - 240.
  • 6Singh SP, Zhang HH, Tsang H, et al. PLZF Regulates CCR6 and Is Critical for the Acquisition and Maintenance of the Thl7 Pheno- type in Human Cells [J]. J Immunol,2015,194(9) :4 350.
  • 7Theodoropoulos DS, Morris MS, Morris DL. Sustained improvement of psoriatic lesions in the course of sublingual immunotherapy for airborne allergens: clinical evidence of cross -tolerance [J ] . Eur Rev M ed Pharmacol Sci, 2015,19 (3) : 392.
  • 8Di Fusco D, Izzo R, Figliuzzi MM, et al. IL- 21 as a therapeutic target in inflammatory disorders[J] . Expert Opin Ther Targets, 2014,18(11):1 329.
  • 9Dunn LK, Gaar LR, Yentzer BA, et al. Acitretin in dermatology: a review [ J ]. J Drugs Dermatol, 2011,10:772 -782.
  • 10王定营.我院226例药品不良反应报告回顾性分析[J].中国药房,2008,19(8):622-624. 被引量:27

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部